Curis
CRIS
#11006
Rank
HK$5.29 M
Marketcap
HK$2.72
Share price
-17.89%
Change (1 day)
-80.11%
Change (1 year)

Operating Margin for Curis (CRIS)

Operating Margin as of July 2026 (TTM): -80.29%

According to Curis's latest financial reports and stock price the company's current Operating Margin is -80.29%. At the end of 2025 the company had an Operating Margin of -80.29%.

Operating Margin history for Curis from 2001 to 2025

Operating Margin at the end of each year

Year Operating Margin Change
2025-80.29%-79.81%
2024-397.77%-15.91%
2023-473.04%-15.18%
2022-557.69%30.71%
2021-426.67%54.57%
2020-276.03%-14.08%
2019-321.28%2.85%
2018-312.38%-42.01%
2017-538.66%-32.88%
2016-802.59%7.2%
2015-748.68%293.47%
2014-190.28%131.66%
2013-82.14%-15.09%
2012-96.73%44.84%
2011-66.78%140.91%
2010-27.72%-76.29%
2009-116.94%-25.43%
2008-156.81%206.87%
2007-51.10%-24.1%
2006-67.32%-74.53%
2005-264.35%-16.21%
2004-315.48%251.65%
2003-89.72%-78.26%
2002-412.69%-94.52%
2001-7,534.60%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Pfizer
PFE
12.01%-114.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
19.79%-124.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-109.76% 36.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
42.23%-152.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-16,748.00% 20,759.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-388.94% 384.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
11.74%-114.62%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.